BioMarin to acquire Alesta Therapeutics for $275 million for potential rare bone disease treatment

1 day ago

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

21 hours ago

Hims & Hers CEO says FTC lawsuit misunderstands how the company works

2 days ago

The startup using AI to help rare disease families develop custom treatments

2 days ago

Court rules companies can't import Gilead medications from overseas

2 days ago

Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'

7 days ago

Trump administration ends Medicaid, CHIP funding for gender-affirming care for children

8 days ago

We're lifting our price target on Cardinal Health after issuing rosy profit guidance

8 days ago

Trump wants to split the MMR vaccine. Experts say that's unlikely

8 days ago

Jazz Pharmaceuticals to buy Actio Biosciences for $820 million

9 days ago

Eli Lilly takes weight-loss pill battle global

9 days ago

Trump signs order calling for fewer childhood vaccines, falsely linking shots to autism

9 days ago

New genetic tests are catching rare diseases before symptoms start

9 days ago

Why we like Boeing's latest deal — plus, what to expect from this health stock

10 days ago

Hunter Biden says Joe Biden's cancer has spread further, 'very painful'

10 days ago

Cyclospora fears lead consumers to lose their appetite for salads

12 days ago

Jim Cramer highlights 5 investing themes — and the stocks to buy for each

13 days ago

Sen. Mitch McConnell says he's left rehab, will work from home

13 days ago

CAMP4 advances rare disease treatment for SYNGAP1 into human trials

13 days ago

Divide between Eli Lilly and Novo Nordisk is widening after latest earnings

13 days ago

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

14 days ago

This stock is more than a way to play GLP-1 boom

14 days ago

Bank of America spends $250M a year on GLP-1 drugs for its employees, CEO says

15 days ago

Eli Lilly blows past estimates, raises outlook on Zepbound and Mounjaro sales

15 days ago

CVS blows past estimates, hikes guidance as insurance unit continues to improve

15 days ago

Novo CEO defends economics of Wegovy pill as lower prices weigh on sales

15 days ago

Chipotle stock falls on potential link to salmonella outbreak in Minnesota

16 days ago

Novo Nordisk shares slide after guidance disappoints investors

16 days ago

P&G will acquire supplements brand Thorne for $3.8 billion, CEO tells CNBC

16 days ago

Pfizer tops estimates, hikes low end of revenue guidance on non-Covid products

16 days ago

Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance

16 days ago

Michigan confirms first two deaths in cyclospora outbreak

17 days ago